Royalty Pharma plc
$33.54B- Market cap
- $24.83B
- Debt
- +$9.33B
- Cash
- −$618.70M
Capital structure 73% equity / 27% debt · EV / Revenue 14.11x · EV / EBITDA 31.91x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RPRX · current priceP/E 35.94x
$63.98Latest market snapshot
Implied fair value · at FTNT's multiple
$114.9879.7% above market
1.78 RPRX EPS (TTM)×64.60x FTNT P/E=$114.98
Market $63.98Implied $114.98
FTNT · current priceP/E 64.60x
$156.32Latest market snapshot
Implied fair value · at RPRX's multiple
$86.9844.4% below market
2.42 FTNT EPS (TTM)×35.94x RPRX P/E=$86.98
Market $156.32Implied $86.98